By expenditures
| Name | Title | Type |
|---|---|---|
| Andra Roethler | INTERNAL AUDIT DIVISION MANAGER | Auditee |
| Michelle Lorenzana | Senior Director | Auditee |
| Chris Knopik | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 362609 | 2024 | 2025-07-21 | Cliftonlarsonallen LLP | $327.24M |
| 322389 | 2023 | 2024-09-30 | Rsm US LLP | $359.54M |
| 51481 | 2022 | 2023-09-28 | Rsm US LLP | $358.68M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 362609 | 2024 | 2025-07-21 | 1148099 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 1148098 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 1148097 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 1148096 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 1148095 | 2024-003 | Material Weakness | Yes | E |
| 362609 | 2024 | 2025-07-21 | 1148094 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 1148093 | 2024-002 | Material Weakness | - | E |
| 362609 | 2024 | 2025-07-21 | 571657 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 571656 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 571655 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 571654 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 571653 | 2024-003 | Material Weakness | Yes | E |
| 362609 | 2024 | 2025-07-21 | 571652 | 2024-004 | Significant Deficiency | - | B |
| 362609 | 2024 | 2025-07-21 | 571651 | 2024-002 | Material Weakness | - | E |
| 322389 | 2023 | 2024-09-30 | 1075979 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 1075978 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 1075977 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 1075976 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 1075975 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 1075974 | 2023-013 | Material Weakness | - | F |
| 322389 | 2023 | 2024-09-30 | 1075973 | 2023-012 | Material Weakness | - | I |
| 322389 | 2023 | 2024-09-30 | 1075972 | 2023-011 | Material Weakness | - | I |
| 322389 | 2023 | 2024-09-30 | 1075971 | 2023-010 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 1075970 | 2023-009 | Significant Deficiency | - | C |
| 322389 | 2023 | 2024-09-30 | 1075969 | 2023-008 | Significant Deficiency | Yes | ABE |
| 322389 | 2023 | 2024-09-30 | 1075968 | 2023-007 | Material Weakness | Yes | E |
| 322389 | 2023 | 2024-09-30 | 1075967 | 2023-006 | Significant Deficiency | Yes | G |
| 322389 | 2023 | 2024-09-30 | 1075966 | 2023-005 | Significant Deficiency | Yes | E |
| 322389 | 2023 | 2024-09-30 | 499537 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 499536 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 499535 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 499534 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 499533 | 2023-004 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 499532 | 2023-013 | Material Weakness | - | F |
| 322389 | 2023 | 2024-09-30 | 499531 | 2023-012 | Material Weakness | - | I |
| 322389 | 2023 | 2024-09-30 | 499530 | 2023-011 | Material Weakness | - | I |
| 322389 | 2023 | 2024-09-30 | 499529 | 2023-010 | Significant Deficiency | - | L |
| 322389 | 2023 | 2024-09-30 | 499528 | 2023-009 | Significant Deficiency | - | C |
| 322389 | 2023 | 2024-09-30 | 499527 | 2023-008 | Significant Deficiency | Yes | ABE |
| 322389 | 2023 | 2024-09-30 | 499526 | 2023-007 | Material Weakness | Yes | E |
| 322389 | 2023 | 2024-09-30 | 499525 | 2023-006 | Significant Deficiency | Yes | G |
| 322389 | 2023 | 2024-09-30 | 499524 | 2023-005 | Significant Deficiency | Yes | E |
| 51481 | 2022 | 2023-09-28 | 626199 | 2022-004 | Material Weakness | - | E |
| 51481 | 2022 | 2023-09-28 | 626198 | 2022-005 | Significant Deficiency | - | ABE |
| 51481 | 2022 | 2023-09-28 | 626197 | 2022-003 | Significant Deficiency | - | G |
| 51481 | 2022 | 2023-09-28 | 626196 | 2022-002 | Significant Deficiency | - | E |
| 51481 | 2022 | 2023-09-28 | 49757 | 2022-004 | Material Weakness | - | E |
| 51481 | 2022 | 2023-09-28 | 49756 | 2022-005 | Significant Deficiency | - | ABE |
| 51481 | 2022 | 2023-09-28 | 49755 | 2022-003 | Significant Deficiency | - | G |
| 51481 | 2022 | 2023-09-28 | 49754 | 2022-002 | Significant Deficiency | - | E |